Formex Revenue and Competitors
Estimated Revenue & Valuation
- Formex's estimated annual revenue is currently $8.8M per year.
- Formex's estimated revenue per employee is $201,000
Employee Data
- Formex has 44 Employees.
- Formex grew their employee count by 10% last year.
Formex's People
Name | Title | Email/Phone |
---|
Formex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Formex?
FORMEX - The Formulation Experts Formex is a pharmaceutical contract development and manufacturing organization focusing on oral and topical dosage forms. Located in San Diego, CA, Formex specializes in bioavailability enhancement of small-molecule APIs, offering innovative formulation technologies such as spray-dry dispersion and hot-melt extrusion. Formex’s array of formulation and analytical services include pre-formulation, API characterization, formulation development, analytical method development, stand-alone analytical testing, ICH stability and storage testing, and cGMP manufacturing. With Formex as your CDMO partner, you can trust that our team of established formulators and analytical scientists have the expertise and cutting-edge technology to create customized solutions for your project’s most difficult challenges.
keywords:N/AN/A
Total Funding
44
Number of Employees
$8.8M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.9M | 44 | 63% | N/A |
#2 | $10.2M | 44 | -4% | N/A |
#3 | $5.1M | 44 | N/A | N/A |
#4 | $5.1M | 44 | -2% | N/A |
#5 | $7.7M | 44 | 2% | N/A |